GE Resuscitation System Recall Issued Due to Infant Death Risk

A recall of Giraffe and Panda brand name resuscitation systems has been reclassified to a Class I recall, after the manufacturer recognized the oxygen and air inlet fittings were reversed during assembly, posing an interference with oxygen delivery to infants and newborns that may cause serious adverse health consequences including death. ย 

The GE Healthcare resuscitation systems recall was initially announced on October 1, 2013, but the FDA designated the action as a Class I recall on February 28. Problems with the systems may cause infants to receive too much or too little oxygen, posing a reasonable probability of serious injury or death.

The Giraffe and Panda resuscitation systems are devices used to resuscitate infants and newborns and regulate body temperature.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

According to information released by the manufacturer, an error during the assembly process may have resulted in the oxygen and air inlet fittings on the back of the resuscitation systems being reversed. This could result in an inaccurate delivery of oxygen to newborns that require heightened or decreased oxygen level treatment. In the event the infants receive incorrect levels of oxygen it may cause death, particularly to those who are critically ill, preterm, or had low birth weight.

The recall includes Giraffe Warmer Resuscitation Systems, Panda Warmer with Resuscitation Systems, Giraffe Stand-Alone Infant Resuscitation Systems, Resuscitation System Upgrade Kits, and Panda Freestanding with Resuscitation Systems. The devices were manufactured by GE Healthcare of Wauwatosa, Wisconsin from April 1, 2007 through October 31, 2013, where they were distributed for sale from October 1, 2007 through October 31, 2013.

Class I recalls are considered the most dangerous because there is a reasonable probability that the use of the recalled item will cause serious adverse health consequences including death.

GE Healthcare sent an Urgent Medical Device Correction letter to all known users on November 18, 2013, that identified the recalled products, the problem, safety instructions, and a return receipt.

GE has encouraged owners to check the recalled product codes to verify if their resuscitation system is affected and to warn all potential users of the safety notification and recommended actions sent in the Urgent Medical Device Correction letter. Customers may contact GE Healthcare for return instructions or general questions at 1-800-345-2700.

Russell Maas
Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโ€™s leading personal injury law firms and oversees the siteโ€™s editorial strategy, including SEO and content development.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.
A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโ€™s lymphoma.
Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.